|
|
||||||||
Departments of Medicine and Physiology, University of Florida and Department of Veterans Affairs Medical Center, Gainesville, Florida 32610
Anoxia-reoxygenation, tumor necrosis factor-
(TNF-
), and angiotensin II (ANG II) have been shown to induce
apoptosis in myocytes. However, the role of these mediators in causing
apoptosis of human coronary artery endothelial cells (HCAEC) is not
known. This study was designed to examine the interaction of these
mediators in induction of apoptosis in HCAEC. Cultured HCAEC were
exposed to anoxia-reoxygenation, TNF-
, and ANG II. TNF-
enhanced
apoptosis of HCAEC (determined by DNA nick-end labeling in situ and DNA laddering) caused by anoxia-reoxygenation. ANG II increased apoptosis beyond that caused by anoxia-reoxygenation and TNF-
. Apoptosis caused by ANG II was reduced by losartan, a specific ANG II type 1 receptor (AT1R) blocker, whereas
PD-123,177, a specific ANG II type 2 receptor blocker, under identical
conditions had minimal effect. The proapoptotic effects of ANG II were
associated with the activation of protein kinase C (PKC). The
importance of PKC activation as a signal transduction mechanism became
evident in experiments wherein treatment of HCAEC with a specific
inhibitor of PKC activation decreased ANG II-mediated apoptosis. Thus
AT1R activation appears to be
responsible for apoptosis caused by ANG II in HCAEC, and
AT1R activation-mediated apoptosis
involves activation of PKC.
angiotensin II; anoxia; reoxygenation; apoptosis; angiotensin II type 1 receptor; angiotensin II type 2 receptor; endothelial cell; signal transduction
This article has been cited by other articles:
![]() |
J. Chen and J. L. Mehta Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1738 - H1745. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Grishko, V. Pastukh, V. Solodushko, M. Gillespie, J. Azuma, and S. Schaffer Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2364 - H2372. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tian, J. Liu, P. Bitterman, and R. J. Bache Angiotensin II modulates nitric oxide-induced cardiac fibroblast apoptosis by activation of AKT/PKB Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1105 - H1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Papp, X. Li, J. Zhuang, R. Wang, and B. D. Uhal Angiotensin receptor subtype AT1 mediates alveolar epithelial cell apoptosis in response to ANG II Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L713 - L718. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. WALTHER, L. OLAH, C. HARMS, B. MAUL, M. BADER, H. HORTNAGL, H.-P. SCHULTHEISS, and G. MIES Ischemic injury in experimental stroke depends on angiotensin II FASEB J, February 1, 2002; 16(2): 169 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Berry, R. Touyz, A. F. Dominiczak, R. C. Webb, and D. G. Johns Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2337 - H2365. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Bascands, J.-P. Girolami, M. Troly, I. Escargueil-Blanc, D. Nazzal, R. Salvayre, and N. Blaes Angiotensin II Induces Phenotype-Dependent Apoptosis in Vascular Smooth Muscle Cells Hypertension, December 1, 2001; 38(6): 1294 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, H. Chen, and J. L. Mehta Angiotensin II via Activation of Type 1 Receptor Upregulates Expression of Endoglin in Human Coronary Artery Endothelial Cells Hypertension, November 1, 2001; 38(5): 1062 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Filippatos, N. Gangopadhyay, O. Lalude, N. Parameswaran, S. I. Said, W. Spielman, and B. D. Uhal Regulation of apoptosis by vasoactive peptides Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L749 - L761. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fujiyama, H. Matsubara, Y. Nozawa, K. Maruyama, Y. Mori, Y. Tsutsumi, H. Masaki, Y. Uchiyama, Y. Koyama, A. Nose, et al. Angiotensin AT1 and AT2 Receptors Differentially Regulate Angiopoietin-2 and Vascular Endothelial Growth Factor Expression and Angiogenesis by Modulating Heparin Binding-Epidermal Growth Factor (EGF)-Mediated EGF Receptor Transactivation Circ. Res., January 19, 2001; 88(1): 22 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Irani Oxidant Signaling in Vascular Cell Growth, Death, and Survival : A Review of the Roles of Reactive Oxygen Species in Smooth Muscle and Endothelial Cell Mitogenic and Apoptotic Signaling Circ. Res., August 4, 2000; 87(3): 179 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Y. Li, Y. C. Zhang, M. I. Philips, T. Sawamura, and J. L. Mehta Upregulation of Endothelial Receptor for Oxidized Low-Density Lipoprotein (LOX-1) in Cultured Human Coronary Artery Endothelial Cells by Angiotensin II Type 1 Receptor Activation Circ. Res., May 14, 1999; 84(9): 1043 - 1049. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |